These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
311 related items for PubMed ID: 23137883
1. Pulmonary manifestations of anti-ARS antibody positive interstitial pneumonia--with or without PM/DM. Takato H, Waseda Y, Watanabe S, Inuzuka K, Katayama N, Ichikawa Y, Yasui M, Fujimura M. Respir Med; 2013 Jan; 107(1):128-33. PubMed ID: 23137883 [Abstract] [Full Text] [Related]
5. Clinical characteristics of dermatomyosits/polymyositis associated interstitial lung disease according to the autoantibody. Kishaba T, McGill R, Nei Y, Ibuki S, Momose M, Nishiyama K, Nagano H, Yamashiro S. J Med Invest; 2018 Jan; 65(3.4):251-257. PubMed ID: 30282869 [Abstract] [Full Text] [Related]
6. The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies. Tanizawa K, Handa T, Nakashima R, Kubo T, Hosono Y, Watanabe K, Aihara K, Ikezoe K, Sokai A, Nakatsuka Y, Taguchi Y, Hatta K, Noma S, Kobashi Y, Yoshizawa A, Oga T, Hirai T, Chin K, Nagai S, Izumi T, Mimori T, Mishima M. Respir Med; 2017 Jun; 127():57-64. PubMed ID: 28461123 [Abstract] [Full Text] [Related]
9. Prognostic significance of anti-aminoacyl-tRNA synthetase antibodies in polymyositis/dermatomyositis-associated interstitial lung disease: a retrospective case control study. Hozumi H, Enomoto N, Kono M, Fujisawa T, Inui N, Nakamura Y, Sumikawa H, Johkoh T, Nakashima R, Imura Y, Mimori T, Suda T. PLoS One; 2015 Jun; 10(3):e0120313. PubMed ID: 25789468 [Abstract] [Full Text] [Related]
11. Risk factors for the recurrence of interstitial lung disease in patients with polymyositis and dermatomyositis: a retrospective cohort study. Nakazawa M, Kaneko Y, Takeuchi T. Clin Rheumatol; 2018 Mar; 37(3):765-771. PubMed ID: 28975463 [Abstract] [Full Text] [Related]
12. Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease. Gono T, Kaneko H, Kawaguchi Y, Hanaoka M, Kataoka S, Kuwana M, Takagi K, Ichida H, Katsumata Y, Ota Y, Kawasumi H, Yamanaka H. Rheumatology (Oxford); 2014 Dec; 53(12):2196-203. PubMed ID: 24970922 [Abstract] [Full Text] [Related]
15. [Prognosis of interstitial pneumonitis (IP) in polymyositis (PM)/dermatomyositis (DM)]. Saeki T, Suzuki E, Watanabe T, Saito Y, Itou S, Honma T, Sato T, Nakano M, Arakawa M. Ryumachi; 1994 Feb; 34(1):16-21. PubMed ID: 8146722 [Abstract] [Full Text] [Related]
16. Efficacy of Glucocorticoids and Calcineurin Inhibitors for Anti-aminoacyl-tRNA Synthetase Antibody-positive Polymyositis/dermatomyositis-associated Interstitial Lung Disease: A Propensity Score-matched Analysis. Hozumi H, Fujisawa T, Nakashima R, Yasui H, Suzuki Y, Kono M, Karayama M, Furuhashi K, Enomoto N, Inui N, Nakamura Y, Mimori T, Suda T. J Rheumatol; 2019 May; 46(5):509-517. PubMed ID: 30647164 [Abstract] [Full Text] [Related]
17. Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies. Yoshifuji H, Fujii T, Kobayashi S, Imura Y, Fujita Y, Kawabata D, Usui T, Tanaka M, Nagai S, Umehara H, Mimori T. Autoimmunity; 2006 May; 39(3):233-41. PubMed ID: 16769657 [Abstract] [Full Text] [Related]
18. Nonspecific interstitial pneumonia associated with polymyositis and dermatomyositis: serial high-resolution CT findings and functional correlation. Arakawa H, Yamada H, Kurihara Y, Nakajima Y, Takeda A, Fukushima Y, Fujioka M. Chest; 2003 Apr; 123(4):1096-103. PubMed ID: 12684299 [Abstract] [Full Text] [Related]
20. Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine. Nawata Y, Kurasawa K, Takabayashi K, Miike S, Watanabe N, Hiraguri M, Kita Y, Kawai M, Saito Y, Iwamoto I. J Rheumatol; 1999 Jul; 26(7):1527-33. PubMed ID: 10405940 [Abstract] [Full Text] [Related] Page: [Next] [New Search]